UK markets open in 6 hours 21 minutes
NIKKEI 225
38,111.70 -162.35 (-0.42%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
79.26 +0.26 (+0.33%) GOLD FUTURES
2,333.20 +22.20 (+0.96%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
46,190.57 -1,933.25 (-4.02%)
Sun Pharmaceutical Industries Limited (SUNPHARMA.BO)
BSE - BSE Real-time price. Currency in INR
Add to watchlist
At close: 03:46PM IST
Currency in INR
Valuation measures4
| Market cap (intra-day) | 3.60T |
| Enterprise value | 3.47T |
| Trailing P/E | 40.49 |
| Forward P/E | 26.67 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 7.73 |
| Price/book (mrq) | 6.03 |
| Enterprise value/revenue | 7.43 |
| Enterprise value/EBITDA | 25.96 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.53 |
| 52-week change 3 | 55.93% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 1,638.70 |
| 52-week low 3 | 922.55 |
| 50-day moving average 3 | 1,562.77 |
| 200-day moving average 3 | 1,287.07 |
Share statistics
| Avg vol (3-month) 3 | 122.91k |
| Avg vol (10-day) 3 | 76.57k |
| Shares outstanding 5 | 2.4B |
| Implied shares outstanding 6 | 2.43B |
| Float 8 | 1.06B |
| % held by insiders 1 | 54.69% |
| % held by institutions 1 | 26.76% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 12.5 |
| Forward annual dividend yield 4 | 0.83% |
| Trailing annual dividend rate 3 | 12.50 |
| Trailing annual dividend yield 3 | 0.82% |
| 5-year average dividend yield 4 | 0.93 |
| Payout ratio 4 | 31.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 09 Feb 2024 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 29 Jul 2013 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Mar 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 18.77% |
| Operating margin (ttm) | 22.05% |
Management effectiveness
| Return on assets (ttm) | N/A |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 474.45B |
| Revenue per share (ttm) | 197.74 |
| Quarterly revenue growth (yoy) | 10.10% |
| Gross profit (ttm) | N/A |
| EBITDA | 128.15B |
| Net income avi to common (ttm) | 89.06B |
| Diluted EPS (ttm) | 37.11 |
| Quarterly earnings growth (yoy) | 16.50% |
Balance sheet
| Total cash (mrq) | 148.33B |
| Total cash per share (mrq) | 61.71 |
| Total debt (mrq) | 19.28B |
| Total debt/equity (mrq) | 3.05% |
| Current ratio (mrq) | N/A |
| Book value per share (mrq) | 249.32 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.